Medicinal Cannabis Matters: Friday Roundup - 1 May 2026

Connecting the Industry at Cannabis Europa London 2026

This year’s Cannabis Europa event in London is set to be one of the most significant events for the medicinal cannabis industry, particularly following recent changes in global policy.

As reported by Business of Cannabis, the event, which takes place later this month, brings together people from across the industry to discuss the future of medicinal cannabis across Europe and beyond.

Medicann will be attending this year’s event, engaging with industry experts and contributing to conversations around patient access, clinical standards and the continued development of safe care.

New Guidance for Patients Traveling with Medicinal Cannabis

For many patients, travelling with prescribed medicinal cannabis can still feel uncertain. New guidance published by The Cannabis Industry Council and reported by Cannabis Health News aims to address this, offering clearer information on how patients can travel safely and legally with their medication.

The guidance outlines practical considerations such as documentation, prescription proof and checking local regulations before travelling. As more patients access treatment, it’s important that they have clarity to ensure continuity of care and reduce unnecessary stress.

Improved guidance like this helps individuals manage their treatment safely wherever they are.

US Reclassification Signals Global Shift

In a significant international development, the US administration has moved to reclassify cannabis, marking a major shift in how it is viewed at a federal level.

This change is expected to influence regulation and investment across the industry. While the UK operates under its own regulatory system, developments of this scale often have wider implications, contributing to a growing global evidence base and increased momentum for reform.

For patients, changes like this can ultimately support better access to safe and effective treatments.

New Insights from Ancient China On the History of Cannabis

A fascinating article from Leafie explores new evidence suggesting that cannabis was cultivated as a core crop in ancient China. These findings add to the long history of cannabis use, highlighting its role in human society for thousands of years.

While modern medicinal cannabis is based in clinical research and regulation, historical insights offer context for how long this plant has been valued for its practical and therapeutic properties.

Understanding this history helps frame today’s conversation, not as something entirely new, but as part of a much longer story that continues to evolve through science and medicine.

From global policy shifts to practical patient guidance and shared industry knowledge, each development contributes to a more informed and accessible future. As awareness continues to grow, the focus remains on safe, regulated care and ensuring that patients have the understanding and confidence to explore treatment options supported by specialist clinicians.

If you are considering whether medicinal cannabis may be suitable for your condition, you can check your eligibility online in just a couple of minutes. The process is confidential and provides a clear starting point before speaking with a clinician.

Disclaimer: This blog post and the following featured articles are for information only and any articles on external platforms may be amended at any time. Articles that we refer to in our weekly roundup do not reflect the views of Medicann.